Sounduct is thrilled to announce a major funding milestone with a successful raise of €3,000,000, underscoring its commitment to revolutionizing audiology with breakthrough Medtech solutions. As a pioneering start-up, Sounduct is on a mission to redefine hearing health by providing deaf individuals with access to high-performance hearing through its innovative, non-invasive, and non-destructive device. This cutting-edge technology harnesses deeptech innovations to offer a seamless blend of safety and efficiency, making it a game changer in the field of audiology.
Founded on a vision to empower people with hearing impairments, Sounduct has built a robust platform that integrates advanced technology with patient-centric design. The recent injection of funds will be dedicated to further developing and refining its flagship device, scaling production capabilities, and accelerating market entry. This investment also supports continued research and development, ensuring that Sounduct remains at the forefront of deeptech innovation in healthcare.
Additionally, Sounduct benefits from strategic incubation support provided by SEMIA, Quest for Health, and Quest for Industry in Strasbourg—a testament to its strong foundation in both technological and industrial excellence. This funding milestone is further bolstered by recognitions from notable entities such as France 2030, Fondation Force, Région Grand Est, and BPI France, affirming the company’s potential and the transformative nature of its work.
This funding achievement marks an exciting new chapter for Sounduct. With this capital, the company is well-positioned to accelerate its growth, enhance its technological offerings, and ultimately make a significant impact on the lives of individuals with hearing impairments worldwide. Sounduct continues to lead the charge in converting innovative ideas into practical, life-changing solutions in the realm of audio health.
